Sunshine Biopharma (SBFM) Preferred Shares (2010 - 2026)
Sunshine Biopharma (SBFM) posted Preferred Shares of $13000.0 for Q1 2026, little changed on a QoQ basis from $13000.0 in Q4 2025, and little changed year-over-year from $13000.0 in Q1 2025.
Sunshine Biopharma (SBFM) Preferred Shares (2010 - 2026) Analysis & Trends
Sunshine Biopharma's Preferred Shares history runs 11 years deep, the most recent figure standing at $13000.0 for Q1 2026.
- Quarterly Preferred Shares changed 0.0% year-over-year to $13000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13000.0 (changed 0.0% YoY) and the FY2025 annual result came in at $13000.0, changed 0.0% from the prior year.
- Preferred Shares was $13000.0 for Q1 2026 at Sunshine Biopharma, roughly flat from $13000.0 in the prior quarter.
- Across five years, Preferred Shares topped out at $13000.0 in Q1 2024 and bottomed at $1000.0 in Q1 2022.
- A 5-year average of $7352.9 and a median of $13000.0 in 2024 frame the typical range for Preferred Shares.
- Annual changes were most pronounced in 2022 — Preferred Shares tumbled 99.0% — and 2024, when it soared 1200.0%.
- Sunshine Biopharma's Preferred Shares stood at $1000.0 in 2022, then changed by 0.0% to $1000.0 in 2023, then surged by 1200.0% to $13000.0 in 2024, then changed by 0.0% to $13000.0 in 2025, then changed by 0.0% to $13000.0 in 2026.
- Business Quant data shows SBFM's Preferred Shares at $13000.0 in Q1 2026, $13000.0 in Q4 2025, and $13000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Sunshine Biopharma | 750,608.81 | -6.16 Mn | 2.18 Mn | 13,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13,000.00 |
| Dec 31, 2025 | 13,000.00 |
| Sep 30, 2025 | 13,000.00 |
| Jun 30, 2025 | 13,000.00 |
| Mar 31, 2025 | 13,000.00 |
| Dec 31, 2024 | 13,000.00 |
| Sep 30, 2024 | 13,000.00 |
| Jun 30, 2024 | 13,000.00 |
| Mar 31, 2024 | 13,000.00 |
| Dec 31, 2023 | 1,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Mar 31, 2023 | 1,000.00 |
| Dec 31, 2022 | 1,000.00 |
| Sep 30, 2022 | 1,000.00 |
| Jun 30, 2022 | 1,000.00 |
| Mar 31, 2022 | 1,000.00 |
| Dec 31, 2021 | 100,000.00 |
| Sep 30, 2021 | 100,000.00 |
| Jun 30, 2021 | 100,000.00 |